z-logo
open-access-imgOpen Access
PD-L1 combined with HDAC9 is a useful prognostic predictor in hepatocellular carcinoma
Author(s) -
Yang Zhao,
Lei Zhang,
Jianwei Liu,
Lixue Yang,
Hui Xue,
Shilei Bai,
Kui Wang
Publication year - 2021
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.254
H-Index - 30
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr-20-3415
Subject(s) - hepatocellular carcinoma , immunohistochemistry , tissue microarray , immunotherapy , medicine , blockade , cancer research , pd l1 , oncology , cancer , receptor

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom